Medical, Inc. of Silicon Valley, CA today announces the expansion of
its senior management team with Dr. Rosemary Ku, MD/MBA/MPH joining as
Chief Medical Officer. In this role, Dr. Ku will guide HD Medical’s
product vision and roadmap, interface with the FDA, oversee numerous
clinical trials as well as contribute to marketing and investor
Dr. Rosemary is a practicing physician at Kaiser Permanente and comes to
HD Medical from Lark Health where she served as the Chief Medical
Officer focusing on chronic disease management. She previously served as
Chief Medical and Strategy Officer for Restore Health and helped build
the company from concept through acquisition by Zillion in 2017.
“For-profit companies have typically focused on building new
technologies for consumers with both access and willingness to pay. HD
Medical is different. HD Medical strives to develop the world’s best
cardiac screening and monitoring tools for communities that need it the
most,” said Dr. Ku, Chief Medical Officer at HD Medical, Inc. “With this
mission, the company is rapidly opening new markets at the intersection
of social impact and growth in India and rest of Asia through mass
screening of children for congenital heart disease. HD Medical is
pioneering a model for how companies in Silicon Valley can accelerate
the dissemination of life-changing technology to underserved communities
while still meeting investor expectations. I’m honored to help drive HD
Medical’s clinical validation strategy, social impact, and growth,” adds
“HD Medical’s ability to gather comprehensive cardiovascular data
remotely is a game changer in modern healthcare. The potential to
intervene before catastrophic events can save lives and maximize the
quality of life for those at risk. Dr. Ku will not only help clinically
validate HD Medical’s existing technology but will also leverage
cutting-edge science to develop proprietary tools for the advancement of
cardiac care,” said Arvind Thiagarajan, Founder and CEO of HD Medical,
About HD Medical, Inc.
HD Medical, Inc. is a Silicon Valley-based innovator of digital health
solutions for AI-enabled detection and management of cardiovascular
disease (CVD). The company delivers its intelligent cardiac care
solutions and products globally to medical professionals, hospitals and
medical institutions as well as veterinarians through channel partners.
For more information please visit www.hdmedicalgroup.com.
Note to editors: HD Steth is a registered trademark of HD
Medical, Inc. All other company, organization, product or alliance names
mentioned herein remain the property of their respective owners.